我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

冠心病患者抗心磷脂抗体与PON、ox-LDL、MDA和SOD的相关性

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2014年第4期
页码:
453-455
栏目:
临床研究
出版日期:
2014-04-25

文章信息/Info

Title:
Relationship between anticardiolipin antibody and paraoxonase, ox-LDL, MDA and SOD in patients with coronary heart disease
作者:
白 玲1谭雪峰2刘 平1
(1.西安交通大学医学部第一临床医学院心血管内科,环境与疾病相关基因教育部重点实验室,陕西 西安 710061;
2.泾阳县医院心内科,陕西 咸阳713700)
Author(s):
BAI Ling1 TAN Xue-feng2 LIU Ping1
(1.Department of Cardiovascology, First Affiliated Hospital, Medical School, Xi’an Jiaotong University & Key Laboratory of Environment and Genes Related to Disease, Ministry of Education, Xi’an 710061, Shaanxi, China;
2.Department of Cardiology, Jingyang Hospital, Xianyang 713700, Shaanxi, China)
关键词:
冠状动脉疾病抗心磷脂抗体对氧磷酶
Keywords:
coronary disease anticardiolipin antibody paraoxonase
分类号:
R541.4
DOI:
-
文献标识码:
A
摘要:
目的:观察和分析冠心病患者抗心磷脂抗体(ACA)与血清对氧磷酶(PON)活性、氧化低密度脂蛋白(ox-LDL)、丙二醛(MDA)和超氧化物歧化酶(SOD)的相关性。方法: 酶联免疫法检测118例冠心病患者、68例正常对照者血清ACA、ox-LDL、硫代巴比妥酸法测定MDA、黄嘌呤氧化酶法测定SOD、乙酸苯酯法测定PON。结果: 冠心病患者ACA阳性率为24%,显著高于对照组(阳性率为9%,P<0.05)。ACA阳性冠心病患者PON活性为(122±40) kU/L、ox-LDL为(0.81±0.26) mg/L、MDA为(7.6±1.1) μmol/L、SOD为(72±20) μU/L,与ACA阴性冠心病相比PON活性降低,ox-LDL、MDA升高,SOD无明显变化。相关分析显示PON活性与ox-LDL、MDA呈负相关(分别r=-0.825,P<0.01;r=-0.735,P<0.01),与SOD无相关性。结论: ACA阳性冠心病患者反映脂质过氧化程度的ox-LDL、MDA增高,而PON活性降低。
Abstract:
AIM: To observe and analyze the relationship between anticardiolipin antibody (ACA) and paraoxonase (PON), oxidized low-density lipoprotein (ox-LDL), malondialdehycle (MDA), superoxide dismutase (SOD) in patients with coronary heart disease (CHD). METHODS: ACA and ox-LDL were measured by enzyme-linked immunosorbent assay, MDA by thiobarbiuric acid, SOD by xanthine superoxidase, PON by the method of phenyl acetate in 118 patients with CHD and 68 healthy persons. RESULT: The ACA positive rate of CHD was 24%, which was significantly higher than that of healthy persons (the ACA positive rate was 9%, P<0.05) PON, ox-LDL, MDA, SOD levels were (122±40) kU/L, (0.81±0.26) mg/L, (7.6±1.1) μmol/L and (72±20) μU/ml, respectively, in ACA positive CHD. PON was significantly decreased (P<0.05), ox-LDL and MDA levels were significantly increased (P<0.05), but SOD was not different compared with ACA negative CHD. There was a negative correlation between PON and ox-LDL, MDA by correlation analysis, respectively (r=-0.825, P<0.01; r=-0.735, P<0.01). CONCLUSION: Lipid peroxidation levels (ox-LDL, MDA) were increased and the levels of PON were decreased in ACA-positive CHD.

参考文献/References

[1]Nicolo D,Monestier M.Antiphospholipid antibodies and atherosclerosis[J].Clinical Immonology,2004,112(2):183-189.
[2]Hasunuma Y,Matsuura E,Makita Z,et al.Involvement of beta 2-glycoprotein I and anticardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophages[J].Clin Exp Immunol,1997,107(3):569-573.
[3]杨 盛,张菲斐,韩战营,等.冠心病患者血清对氧磷酶1活性与糖化血红蛋白水平及冠状动脉病变的关系[J].中国动脉硬化杂志,2012,20(4):351-355.
[4]Chung CP,Oeser A,Avalos I,et al.Cardiovascular risk scores and the presence of subclinical coronary artery atherosclerosis in women with systemic lupus erythematosus[J].Lupus,2006,15(9):562-569.
[5]de Leeuw K,Freire B,Smit AJ,et al.Traditional and non-traditional risk factors contribute to the development of accelerated atherosclerosis in patients with systemic lupus erythematosus[J].Lupus,2006,15(10):675-682.
[6]Artenjak A,Lakota K,Frank M,et al.Antiphospholipid antibodies as non-traditional risk factors in atherosclerosis based cardiovascular diseases without overt autoimmunity.A critical updated review[J].Autoimmun Rev,2012,11(12):873-882.
[7]白 玲,马爱群,燕 航.冠心病患者抗磷脂抗体与人巨细胞病毒感染关系的初步研究[J].中国循环杂志,2000,15(3):21-23.
[8]Romero FI,Khamashta M, Hughes GR,et al.Lipoprotein(a):a new path in atherothrombosis[J].Lupus, 2000,9(3):206-209.
[9]迟东升,凌文华,马 静,等.对氧磷酶1 55 Met/Leu、对氧磷酶2 148 Ala/Gly和锰超氧化物歧化酶9 Ala/Val基因多态性与冠心病[J].中华流行病学杂志,2006,27(9):808-813.
[10]Watson AD,Berliner JA,Hama SY,et al.Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein[J].J Clin Invest,1995,96(6):2882-2891.
[11]Sherer N,Shoenfeld N.Antiphospholipid antibody syndrome,antiphospholipid antibodies, and atherosclerosis[J].Curr Atheroscler Rep,2001,3(4):328-333.

备注/Memo

备注/Memo:
收稿日期:2014-01-08.作者简介:白玲,副主任医师,主要从事冠心病、心力衰竭研究 Email: bailingb21@sina.com 共同第一作者:谭雪峰,主治医师 Email:747750715@qq.com
更新日期/Last Update: 2014-05-06